Public outreach
News Show all
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Our mission
Within the new Clinical Research Unit (CRU) “CATCH ALL – towards a cure for all adults and children with Acute Lymphoblastic Leukemia (ALL)”, funded by the German Research Foundation (DFG), an interdisciplinary team of clinicians and basic scientists organized within the University Cancer Center Schleswig-Holstein (UCCSH) at UKSH and in the Kiel Oncology Network (KON) at Kiel University will explore novel approaches for improved precision therapies for ALL patients across all age groups. The overall goal of the CRU is to integrate comprehensive clinical and molecular data from adult and pediatric ALL patients to better understand the molecular and immunological mechanisms driving leukemia persistence to foster clinical translation.
Spokesperson
Prof. Dr. med. Claudia Dorothea Baldus
Department of Internal Medicine II, Hematology and Oncology
University Medical Center Schleswig-Holstein and Christian-Albrechts University Kiel
Arnold-Heller-Str. 3, Haus L, 24105 Kiel
Phone: 0431/500-22501
Fax: 0431/500-22504
E-Mail: claudia.baldus@uksh.de
Research Coordinator – Professorship
Prof. Dr. rer. nat. Matthias Peipp
Department of Internal Medicine II, Division of Antibody-based ImmunotherapyUniversity Medical Center Schleswig-Holstein and Christian-Albrechts University Kiel
Arnold-Heller-Str. 3, Dr. Mildred Scheel-Haus, 24105 Kiel
Phone: +49 431/500-22769
Email: m.peipp@med2.uni-kiel.de
Coordinator
Dr. rer. nat. Claudia Taubenheim
Department of Internal Medicine II, Hematology and Oncology
University Medical Center Schleswig-Holstein
Arnold-Heller-Str. 3, Haus L, 24105 Kiel
Phone: 0431/500-18516
Fax: 0431/500-22504
E-Mail: claudia.taubenheim@uksh.de